Browse

Cessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day: An Alternative Method for Flexible Multiple-Dose Protocol

DC Field Value Language
dc.contributor.authorChang, Hye Jin-
dc.contributor.authorLee, Jung Ryeol-
dc.contributor.authorJee, Byung Chul-
dc.contributor.authorSuh, Chang Suk-
dc.contributor.authorKim, Seok Hyun-
dc.date.accessioned2012-06-04T04:51:01Z-
dc.date.available2012-06-04T04:51:01Z-
dc.date.issued2009-04-
dc.identifier.citationJOURNAL OF KOREAN MEDICAL SCIENCE; Vol.24 2; 262-268ko_KR
dc.identifier.issn1011-8934-
dc.identifier.urihttps://hdl.handle.net/10371/76774-
dc.description.abstractThis study was performed to analyze retrospectively outcomes of stimulated in vitro fertilization (IVF) cycles where the gonadotropin-releasing hormone (GnRH) antagonist was omitted on ovulation triggering day. A total of 92 consecutive IVF cycles were included in 65 women who are undergoing ovarian stimulation with recombinant FSH. A GnRH antagonist, cetrorelix 0.25 mg/day, was started when leading follicle reached 14 mm in diameter until the day of hCG administration (Group A, 66 cycles) or until the day before hCG administration (Group B, 26 cycles). The duration of ovarian stimulation, total dose of gonadotropins, serum estradiol levels on hCG administration day, and the number of oocytes retrieved were not significantly different between the two groups. The total dose of GnRH antagonist was significantly lower in Group B compared to Group A (2.7 +/- 0.8 vs. 3.2 +/- 0.9 ampoules). There was no premature luteinization in the subjects. The proportion of mature oocytes (71.4% vs. 61.7%) and fertilization rate of mature (86.3 +/- 19.7% vs. 71.8 +/- 31.7%) was significantly higher in Group B. There were no significant differences in embryo quality and clinical pregnancy rates. Our results suggest that cessation of the GnRH antagonist on the day of hCG administration during a flexible multiple-dose protocol could reduce the total dose of GnRH antagonist without compromising IVF results.ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN ACAD MEDICAL SCIENCESko_KR
dc.subjectGnRH Antagonistko_KR
dc.subjectOvulation Inductionko_KR
dc.subjectCetrorelixko_KR
dc.subjectFertilizationko_KR
dc.subjecthCG Administrationko_KR
dc.subjectOocyte Maturationko_KR
dc.titleCessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day: An Alternative Method for Flexible Multiple-Dose Protocolko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor장혜진-
dc.contributor.AlternativeAuthor이정렬-
dc.contributor.AlternativeAuthor지병철-
dc.contributor.AlternativeAuthor서창석-
dc.contributor.AlternativeAuthor김석현-
dc.identifier.doi10.3346/jkms.2009.24.2.262-
dc.citation.journaltitleJOURNAL OF KOREAN MEDICAL SCIENCE-
dc.description.citedreferenceLee JR, 2007, FERTIL STERIL, V88, P1344, DOI 10.1016/j.fertnstert.2007.01.013-
dc.description.citedreferenceFrankfurter D, 2007, FERTIL STERIL, V88, P1442, DOI 10.1016/j.fertnstert.2007.01.022-
dc.description.citedreferenceHuirne JA, 2007, HUM REPROD, V22, P2805, DOI 10.1093/humrep/dem270-
dc.description.citedreferenceVenetisi CA, 2007, HUM REPROD UPDATE, V13, P343, DOI 10.1093/humupd/dmm007-
dc.description.citedreferenceIkemoto T, 2007, J MOL ENDOCRINOL, V38, P289, DOI 10.1677/JME-06-0010-
dc.description.citedreferenceAllegra A, 2007, HUM REPROD, V22, P101, DOI 10.1093/humrep/del337-
dc.description.citedreferenceKolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038-
dc.description.citedreferenceChen HJ, 2006, J ASSIST REPROD GEN, V23, P289, DOI 10.1007/s10815-006-9054-0-
dc.description.citedreferenceGriesinger G, 2006, FERTIL STERIL, V85, P791, DOI 10.1016/j.fertnstert.2005.08.048-
dc.description.citedreferenceOlivennes F, 2006, CLIN OBSTET GYNECOL, V49, P12-
dc.description.citedreferenceKolibianakis EM, 2006, HUM REPROD, V21, P352, DOI 10.1093/humrep/dei348-
dc.description.citedreferenceALINANY HG, 2006, COCHRANE DB SYST REV, V3, P1750-
dc.description.citedreferenceSimon C, 2005, HUM REPROD, V20, P3318-
dc.description.citedreferenceMessinis IE, 2005, HUM REPROD, V20, P3192, DOI 10.1093/humrep/dei210-
dc.description.citedreferenceGriesinger G, 2005, HUM REPROD, V20, P2373, DOI 10.1093/humrep/dei086-
dc.description.citedreferenceFauser BCJM, 2005, FERTIL STERIL, V83, P1607, DOI 10.1016/j.fertnstert.2005.02.01-
dc.description.citedreferenceAl-Inany H, 2005, GYNECOL ENDOCRINOL, V20, P161, DOI 10.1080/09513590400027232-
dc.description.citedreferenceHuirne JAF, 2005, HUM REPROD, V20, P359, DOI 10.1093/humrep/deh601-
dc.description.citedreferenceSaadat P, 2004, FERTIL STERIL, V82, P167, DOI 10.1016/j.fertnstert.2003.11.050-
dc.description.citedreferenceKolibianakis EM, 2003, J CLIN ENDOCR METAB, V88, P5632, DOI 10.1210/jc.2003-030805-
dc.description.citedreferenceROULIER R, 2003, REPROD BIOMED ONLINE, V7, P185-
dc.description.citedreferenceAl-Inany H, 2002, HUM REPROD, V17, P874-
dc.description.citedreferenceGrundker C, 2002, J CLIN ENDOCR METAB, V87, P1427-
dc.description.citedreferenceHernandez ER, 2000, HUM REPROD, V15, P1211-
dc.description.citedreferenceOlivennes F, 2000, FERTIL STERIL, V73, P314-
dc.description.citedreferenceOrtmann O, 1999, HUM REPROD, V14, P194-
dc.description.citedreferenceKol S, 1999, HUM REPROD, V14, P2242-
dc.description.citedreferenceMannaerts B, 1998, HUM REPROD, V13, P3023-
dc.description.citedreferencePENG C, 1994, ENDOCRINOLOGY, V135, P1740-
dc.description.citedreferenceDIEDRICH K, 1994, HUM REPROD, V9, P788-
dc.description.citedreferenceHILLIER SG, 1994, HUM REPROD, V9, P188-
dc.description.citedreferenceBROWN JB, 1978, AUSTR NZ J OBSTETRIC, V18, P46-
dc.description.tc1-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Obstetrics & Gynecology (산부인과전공)Journal Papers (저널논문_산부인과학전공)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse